Janus Henderson Group PLC Forma Therapeutics Holdings, Inc. Transaction History

Janus Henderson Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$21.22 - $25.7 $16.5 Million - $20 Million	-776,845 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$22.86 - $30.95 $1.59 Million - $2.15 Million	-69,378 Reduced 8.2%	776,845 $19.3 Million
Q1 2021 May 17, 2021	SELL	$24.58 - $42.82 $6.6 Million - $11.5 Million	-268,486 Reduced 24.09%	846,223 $23.7 Million
Q4 2020 Feb 16, 2021	SELL	$34.9 - $51.08 $12.7 Million - $18.6 Million	-364,633 Reduced 24.65%	1,114,709 $37.8 Million
Q3 2020 Nov 16, 2020	BUY	$32.95 - $50.25 $16.1 Million - $24.5 Million	488,297 Added 49.27%	1,479,342 $72.2 Million
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $38.7 Million - $46.1 Million	991,045 New	991,045 $46.1 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.